Invivyd (IVVD) Depreciation and Depletion (2021 - 2024)
Invivyd (IVVD) posted Depreciation and Depletion of $132000.0 for Q3 2024, up 3.12% on a QoQ basis from $128000.0 in Q2 2024, and up 10.92% year-over-year from $119000.0 in Q4 2023.
Invivyd (IVVD) Depreciation and Depletion (2021 - 2024) Analysis & Trends
Invivyd's Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $132000.0 for Q3 2024.
- Quarterly Depreciation and Depletion rose 10.92% year-over-year to $132000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $502000.0 (up 29.72% YoY) and the FY2023 annual result came in at $480000.0, up 1070.73% from the prior year.
- Depreciation and Depletion was $132000.0 for Q3 2024 at Invivyd, up from $128000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $132000.0 in Q3 2024 and bottomed at $1000.0 in Q4 2021.
- A 4-year average of $75333.3 and a median of $119500.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 2900.0% — and 2024, when it grew 1.67%.
- Invivyd's Depreciation and Depletion stood at $1000.0 in 2021, then jumped by 2600.0% to $27000.0 in 2022, then jumped by 344.44% to $120000.0 in 2023, then increased by 10.0% to $132000.0 in 2024.
- Business Quant data shows IVVD's Depreciation and Depletion at $132000.0 in Q3 2024, $128000.0 in Q2 2024, and $122000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 132,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Dec 31, 2023 | 120,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 121,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Mar 31, 2023 | 120,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Dec 31, 2022 | 27,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |